Diabetic retinopathy is a leading cause of blindness, making early detection of this condition crucial. Dr Yong Shao Onn from the Eagle Eye Centre at Mt Alvernia Hospital, Singapore, speaks to Roshini Claire Anthony on the diagnosis and treatment options.
Refractive errors are ocular disorders that occur when the optical power of the eye produces an object image that is not focused on the retina. Although easily correctable in developed countries, the global burden of uncorrected refractive errors is enormous, with an estimated 145 million visually impaired and 8 million blind individuals.
Audrey Abella spoke with Dr Inez Wong, senior consultant ophthalmologist and director of paediatric ophthalmology and strabismus service at the Eagle Eye Centre in Singapore, on how GPs can manage refractive errors in the primary care setting.
Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.